1988
DOI: 10.1136/bmj.296.6627.969-a
|View full text |Cite
|
Sign up to set email alerts
|

Increasing doses of naloxone hydrochloride by infusion to treat pain due to the thalamic syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
7
0

Year Published

1989
1989
2022
2022

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 6 publications
0
7
0
Order By: Relevance
“…The death rate by alcoholism poses a serious threat to the physical and mental health of patients. After drinking, alcohol enters the blood via the blood capillaries of the stomach and small intestines in a short period of time [5]. The alcohol concentration will reach its peak value within 30~45 min, and then be on a downward trend.…”
Section: Discussionmentioning
confidence: 99%
“…The death rate by alcoholism poses a serious threat to the physical and mental health of patients. After drinking, alcohol enters the blood via the blood capillaries of the stomach and small intestines in a short period of time [5]. The alcohol concentration will reach its peak value within 30~45 min, and then be on a downward trend.…”
Section: Discussionmentioning
confidence: 99%
“…In a recent report on the effect of naloxone in this condition, the authors quoted only 4 patients.4 Obviously, further controlled clinical studies are required to verify pizotifen's beneficial effect in deafferentation pain, a condition for which no oral therapy with proven benefit at present exists.…”
Section: Discussionmentioning
confidence: 99%
“…I report here on the beneficial effect of pizotifen,6 a 5-hydroxytryptamine (5-HT) antagonist, in 4 elderly patients with deafferentation pain.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Pharmacological treatment with multiple drugs including antidepressant, antiepileptic, and opioid medications can be effective, but treatment is often frustrating to both patients and physicians (Carrieri et al 1998;Holtom 2000;Ray and Tai 1988). Motor cortex stimulation and deep brain stimulation (DBS) are sometimes attempted in select patients; however, outcomes are not as good in the CPSP population as in patients with peripheral neuropathies (Levy et al 1987;Machado et al 2007;Nguyen et al 2000;Plow et al 2012).…”
mentioning
confidence: 99%